(MedPage Today) — In a Medicare population with inflammatory bowel disease (IBD), no higher risk of major cardiovascular events such as heart attacks or strokes was observed for patients taking immunomodulators or biologics versus 5-aminosalicylic…
Source:
www.medpagetoday.com
Medical Disclaimer:
This content is shared for informational and educational purposes only.
It does not constitute medical, legal, or policy advice.
Healthcare decisions should always be made in consultation with qualified professionals.
